Edwards Lifesciences Business Segments
Business, geographic, and product segment breakdowns
Edwards Lifesciences generates $6.3B in annual revenue across 4 key segments: Europe ($1.6B), Japan ($363.5M), Rest of World ($679.9M), and United States ($3.6B). The company-wide operating margin is 21.37%. Based on the Q1 2026 filing.
Latest FilingQ1 2026
Report Date2026-05-06
Market Cap$49.4B
P/E Ratio45.05
ROE10.72%